Pharmalogical Consideration of Infectious Disease and Agents

Pandemic, epidemic and endemic infectious diseases are united by a standard problem: how do we quickly and cost-effectively determine potential pharmacological arbitration to treat infections? The growing accessibility of parasite genome data provides the basis for developing methods to prioritize, a priori potential drug targets and analyze the pharmacological landscape of an infectious disease. Infectious diseases create totally different threats to different constituencies and thus are often treated as separate problems by governments, businesses, philanthropies and research funders: neglected diseases are treated as  world health problems; emerging and pandemic diseases  as public health issues; and bio-defence as a national security issue.

    Related Conference of Pharmalogical Consideration of Infectious Disease and Agents

    September 06-07, 2021

    11th World Congress on Rare Diseases and Orphan Drugs

    Berlin, Germany
    September 13-14, 2021

    4th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    October 21-22, 2021

    International Conference on Tropical Diseases and Cure

    Zurich, Switzerland
    November 22-23, 2021

    3rd World Congress on Advancements in Tuberculosis and Lung Diseases

    Singapore City, Singapore
    February 07-08, 2022

    9th International Congress on Infectious Diseases

    Aberdeen, UK

    Pharmalogical Consideration of Infectious Disease and Agents Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in